Interview with Erika Koppers, COO & GM, Roche SA
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Address: 34 Essex Terrace, Westville, 3630, Durban,South Africa
Tel: +27 (0)31 266 9090
Our Vision
“Health systems supporting health for all in southern Africa.”
Our Mission
To contribute to building comprehensive, effective, efficient and equitable national health systems by supporting the implementation of functional health districts in South Africa and the southern African region.
Our Core Values
Our work is guided by the following key values:
Transparency and accountability
Innovation and responsiveness
Integrity and nurturance
Embracing diversity
Participatory management
Continuous Quality Improvement
Our Approach
We embrace a public health perspective with a focus on the primary health care approach.
We do health systems development through research and information dissemination that influences both policy and practice.
We improve quality of care in priority health programmes through facilitating supportive interventions and sharing ‘good practice’.
We advocate for equity, efficiency and effectiveness in health services and for the empowerment of the health service users.
We operate efficiently and effectively through utilising HST’s synergistic multi-disciplinary approach.
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
See our Cookie Privacy Policy Here